key: cord-0429990-gfx723b5
authors: Eltobgy, Mostafa; Zani, Ashley; Kenney, Adam D.; Estfanous, Shady; Kim, Eunsoo; Badr, Asmaa; Carafice, Cierra; Daily, Kylene; Whitham, Owen; Pietrzak, Maciej; Webb, Amy; Kawahara, Jeffrey; Eddy, Adrian C.; Denz, Parker; Lu, Mijia; Mahesh, KC; Peeples, Mark E.; Li, Jianrong; Zhu, Jian; Que, Jianwen; Robinson, Richard; Mejia, Oscar Rosas; Rayner, Rachael E.; Hall-Stoodley, Luanne; Seveau, Stephanie; Gavrilin, Mikhail A.; Tedeschi, Andrea; Partida-Sanchez, Santiago; Roberto, Frank; Hemann, Emily A.; Abdelrazik, Eman; Forero, Adriana; Nimjee, Shahid M.; Boyaka, Prosper; Cormet-Boyaka, Estelle; Yount, Jacob S.; Amer, Amal O.
title: Caspase-4/11 exacerbates disease severity in SARS-CoV-2 infection by promoting inflammation and thrombosis
date: 2021-09-25
journal: bioRxiv
DOI: 10.1101/2021.09.24.461743
sha: 0e3518d24bff080e331f36b309ac470eee16862b
doc_id: 429990
cord_uid: gfx723b5

SARS-CoV-2 is a worldwide health concern, and new treatment strategies are needed 1. Targeting inflammatory innate immunity pathways holds therapeutic promise, but effective molecular targets remain elusive. Here, we show that human caspase-4 (CASP4), and its mouse homologue, caspase-11 (CASP11), are upregulated in SARS-CoV-2 infections, and that CASP4 expression correlates with severity of SARS-CoV-2 infection in humans. SARS-CoV-2-infected Casp11-/- mice were protected from severe weight loss and lung pathology, including blood vessel damage, compared to wild-type (WT) and gasdermin-D knock out (Gsdmd-/-) mice. GSDMD is a downstream effector of CASP11 and CASP1. Notably, viral titers were similar in the three genotypes. Global transcriptomics of SARS-CoV-2-infected WT, Casp11-/- and Gsdmd-/- lungs identified restrained expression of inflammatory molecules and altered neutrophil gene signatures in Casp11-/- mice. We confirmed that protein levels of inflammatory mediators IL-1β, IL6, and CXCL1, and neutrophil functions, were reduced in Casp11-/- lungs. Additionally, Casp11-/- lungs accumulated less von Willebrand factor, a marker for endothelial damage, but expressed more Kruppel-Like Factor 2, a transcription factor that maintains vascular integrity. Overall, our results demonstrate that CASP4/11, promotes detrimental SARS-CoV-2-associated inflammation and coagulopathy, largely independently of GSDMD, identifying CASP4/11 as a promising drug target for treatment and prevention of severe COVID-19.

pathogen-sensing pathways and other inflammasome components in mediating host defense 70 versus immune-mediated pathology and thrombosis during SARS-CoV-2 infection in vivo remains 71 unclear 7 . While effector molecules downstream of infection-sensing pathways, such as specific 72 inflammatory cytokines, have been targeted in attempts to limit virus-induced tissue damage, 73 most of these strategies failed to exert major benefits in human clinical trials 8 . Therefore, 74 strategies targeting molecules upstream of multiple inflammatory cytokines or chemokines may 75 be more effective, though this remains to be experimentally tested. Here, we investigate the role 76 of a major member of the non-canonical inflammasome, caspase-11 (CASP11), and its 77 downstream effector Gasdermin D (GSDMD) in SARS-CoV-2 infection and disease severity using 78 knockout mouse models and mouse-adapted SARS-CoV-2.

Caspases are a family of cysteine proteases that specifically cleave their substrates at the 80 C-terminal side of aspartic acid residues. CASP11 is a murine protein that is critical for defense 81 against bacterial pathogens. Human caspase-4 (CASP4) displays high homology to murine 82 CASP11 9,10 and we have demonstrated that human CASP4 mediates many functions of mouse 83 CASP11 in macrophages during bacterial infections 9 . CASP4/11 is a component of the non-84 canonical inflammasome with multiple functions that remain to be fully characterized. One major 85 role for this protein is the cleavage of GSDMD 11 . Once cleaved, the GSDMD N-terminal fragment 86 inserts into the plasma membrane of eukaryotic cells to form pores that allow the release of IL-1β 87 and other molecules, sometimes leading to cell lysis and death known as pyroptosis 12 .

Interestingly, accumulating evidence has posited potential roles for GSDMD downstream of 

revealed that CASP4 is highly expressed in the airway of SARS-CoV-2-infected patients, and that 105 expression levels increase with disease severity (Fig. 1a) . Additionally, we found that human lung 106 sections from COVID-19 patients show higher levels of CASP4 staining compared with healthy 107 lung controls (Fig. 1b) , owing to greater numbers of CASP4 positive cells in the infected lung 108 tissue (Fig. 1c) . We then performed intranasal infection of C57BL/6 wild-type (WT) mice with 109 pathogenic mouse-adapted SARS-CoV-2 (strain MA10) 15 , and found that infection strongly 110 induces Casp11 expression throughout murine lung tissue within 4 days of infection as detected 111 by RNAscope in situ hybridization (ISH) (Fig. 1d) and confirmed by qRT-PCR (Fig. 1e) . The level 112 of CASP11 protein, likewise, went from below detection to highly-expressed in response to SARS-

CoV-2 infection of murine lungs (Fig. 1f) . We further examined infection of K18-hACE2 mice 114 expressing the human ACE2 receptor using human isolate SARS-CoV-2 strain USA-WA1/2020 115 (WA1). Similar to mouse adapted SARS-CoV-2, the non-adapted human virus strongly induced 116 the lung expression of CASP11 as demonstrated by qRT-PCR (Fig. 1g) 16 . Overall, CASP4 is 117 highly expressed in the lungs of COVID-19 patients, and CASP11 is similarly induced upon 

MA10 for comparison of weight loss, a commonly used indicator of overall infection severity in 124 mice 16 . We found that WT mice lost a significant percentage of their body weight between days 125 1 and 4 post-infection, followed by partial recovery of weight up to day 7, at which point we ended 126 our experiments (Fig. 2a) . Casp11 -/mice, on the other hand, lost weight only up to day 3, and 127 then rapidly recovered fully to their original weight by day 5 (Fig. 2a) . In comparison, weight loss 128 of Gsdmd -/mice was not significantly different from that of WT mice (Fig. 2a) . These data indicate 129 that CASP11 promotes disease severity during SARS-CoV-2 infection, and that this function is 130 not mediated by GSDMD.

To determine whether differences in disease severity could be explained by differences in 132 viral replication, we quantified live virus titers in WT, Casp11 -/and Gsdmd -/mouse lungs at 2 and 133 4 days post-infection. We found that viral loads were similar with no statistical difference between 134 the mice genotypes at either time point (Fig. 2b) . We also observed that, in agreement with 135 previous reports 17 , viral titers were decreased at day 4 compared with day 2 in all groups, 136 demonstrating that neither CASP11 nor GSDMD are required for viral clearance mechanisms ( Fig. 2b) . To corroborate these findings, lung sections from WT and Casp11 -/mice were stained 138 for SARS-CoV-2 nucleocapsid protein and similar staining patterns were observed with prominent 139 infection of cells lining the airways and neighboring alveoli (Fig. 2c) . Overall, these results 140 demonstrate that loss of CASP11, but not GSDMD, prevents severe disease in SARS-CoV-2 141 infection without affecting virus replication or clearance. Gsdmd -/infected lungs were seen using dimensionality reduction approaches, while the Casp11 -

/infected lung profiles showed greater divergence in gene expression patterns (Fig. 2d) . We Fig. 1b,c) . 170 signaling as highlighted in (Fig. 2e) . Knockout of Gsdmd, had less impact on the magnitude of cytokine and chemokine expression compared to Casp11 knockout (Fig. 2f) infected control tissue (Fig 3a) . However, WT and Gsdmd -/lung sections showed more severe 182 tissue consolidation and cell infiltration throughout a greater portion of the lung than that seen in 183 Casp11 -/mice. We thus quantified cell area versus airway space to determine cellularity scores 184 indicative of pathology for tissue sections from individual mice 21 . We observed significantly 185 decreased SARS-CoV-2-induced lung pathology in Casp11 -/mice compared to WT and Gsdmd -186 /mice ( Fig. 3a,b) , correlating with the preservation of Casp11 -/mice body weight and their faster 187 recovery that (Fig. 2a) .

Guided by our transcriptomic results indicating that a critical subset of inflammatory 189 mediators are controlled by CASP11 (Fig. 2f) , we measured levels of CXCL1, IL-1β, and IL-6 by 190 ELISA in lung homogenates from infected animals at 2 and 4 days post-infection (Fig. 3c,d) . 1β was lower in the lungs of both Casp11 -/and Gsdmd -/mice at 2 days post-infection when 192 compared to WT (Fig. 3c) . Moreover, IL-1β staining in lung tissue sections revealed more IL-1β 193 in WT SARS-CoV-2 infected mice than Casp11 -/infected ones (Supplementary Fig. 2) . On the 194 other hand, the production of CXCL1 was dependent on Casp11 at both time-points, and 195 independent of Gsdmd (Fig. 3c,d) . Average levels of IL-6 were partially decreased in Casp11 -/-196 lungs with a statistically significant difference between WT and Casp11 -/lungs at day 4 ( Fig.   197 3c,d). These results corroborate and expand our day 2 transcriptomic analysis in which 198 expression of Il1b and Cxcl1 was decreased (Fig. 2f) , and demonstrate that production of a critical 199 subset of inflammatory mediators in the lung is dependent on CASP11 during SARS-CoV-2 200 infection.

To determine the role of CASP11 in the response of lung macrophages to SARS-CoV-2, 202 we purified mature primary macrophages from lungs of WT and Casp11 -/mice, and infected them 203 with SARS-CoV-2 MA10. Culture supernatants and cellular RNA were collected and measured 204 for IL-1β, IL-6 and CXCL1 protein and transcript levels, respectively. Compared with non-infected cells, CXCL1 protein and RNA transcripts were detected at high levels upon infection of WT 206 macrophages, but were poorly produced by Casp11 -/cells (Fig. 3e,f) . Interestingly, IL-1β 207 transcripts were also induced in a CASP11-dependent manner, but secreted protein was not 208 detected in either group (Fig. 3e,f) . Distinctly, protein and transcript levels of IL-6 did not 209 significantly differ between WT and Casp11 -/cells (Fig. 3e,f) . These results confirm our in vivo 210 measurements and further demonstrate that CASP11 is an important cellular regulator of specific 211 cytokines and chemokines, including CXCL1 and IL-1b, in response to SARS-CoV-2. (Fig. 3g, Supplementary Fig. 1d) . Additionally, genes 220 associated with the response to tissue damage from neutrophils (Slpi and Lair1) were also 221 decreased in the absence of Casp11 relative to WT lungs (Fig. 3g) . These results are consistent 222 with decreased gene expression for the neutrophil chemoattractant CXCL1 (Fig. 3c,d) , as well 223 as with previous reports of neutrophil regulation by CASP11 through effects on actin 9,19 .

Notably, expression of these neutrophil signature genes in Gsdmd -/lungs was less 225 affected than in Casp11 -/lungs ( Fig. 3g) 

Overall, these analyses most prominently demonstrate that CASP11 is required for robust 231 production of specific inflammatory mediators as well as neutrophil recruitment and functions in 232 the lung during SARS-CoV-2 infection.

To further examine the role of neutrophils in SARS-CoV-2 infection, lung sections from 234 WT, Casp11 -/and GsdmD -/were stained for the neutrophil marker Ly6G (Fig. 3h) . Quantification 

CoV-2 infection, WT, Casp11 -/and Gsdmd -/neutrophils were treated with PMA (Fig. 4a,) , or 246 culture supernatants of WT epithelial cells infected with SARS-CoV-2 (Supplementary Fig. 3 ).

Notably, Casp11 -/neutrophils failed to form NETs in response to all conditions. In contrast, 

RNAscope in situ hybridization (ISH) technology, we found significantly more blood vessels 261 expressing VWF mRNA in the lung vascular architecture of SARS-CoV-2 infected WT mice when 262 compared to Casp11 -/lungs at day 4 post-infection (Fig. 4b, Supplementary Fig. 4) . Immunoblot 263 analysis of lung homogenates confirmed that VWF was significantly lower in lungs of Casp11 -/-264 mice when compared to WT lungs (Fig. 4c,d) . Notably, lung sections from SARS-CoV-2-infected 265 Gsdmd -/showed more staining for VWF than Casp11 -/mice (Fig. 4b) . Therefore, CASP11 is 266 required for the accumulation of VWF in the lungs during SARS-CoV-2 infection. To determine 267 the source of VWF, lung sections from Casp11 -/and Gsdmd -/mice were processed for the 268 simultaneous detection of endothelial marker VEGF receptor 1 (FLT1) and VWF mRNA 26 . We 269 found that VWF RNA colocalized with FLT1, which was also upregulated in WT and Gsdmd -/but 270 not Casp11 -/lung sections (Fig. 4f, Supplementary Fig. 5) . Furthermore, we examined the 271 expression of Kruppel-Like Factor 2 (KLF2) in WT and Casp11 -/-SARS-CoV-2-infected lungs.

KLF2 is an endothelial protective transcription factor that exerts anti-inflammatory and anti-thrombotic functions in the vascular endothelial cell and maintains the integrity of the endothelial 274 vasculature. We found that KLF2 expression is significantly reduced after SARS-CoV-2-infection 275 in WT lungs, but largely preserved in Casp11 -/infected lungs (Fig. 4e) . Moreover, we examined 276 the vascular architecture in the cleared lungs of SARS-CoV-2 infected mice by using fluorophore 277 conjugated albumin and tissue clearing (Supplementary Fig 6) . The vascular tracing revealed 278 distinctive vascular features in WT SARS-CoV-2-infected lungs with pronounced vascular 279 thickening and angiogenesis/neovascularization (Fig. 4g) . In stark contrast, Casp11 -/infected 280 lung vasculature did not show these abnormalities, confirming less endothelial 281 damage/dysfunction (Fig. 4g) . Taken together, we conclude that CASP11 contributes to Together, our findings suggest that targeting the CASP11 homologue, human CASP4, 372 during COVID-19 will prevent severe pneumonia, inflammation, tissue damage as well as 373 thrombosis and accompanying repercussions such as low oxygen, lung failure, need for 374 ventilators and perhaps long-term sequela. These advantageous effects will be achieved without compromising viral clearance. It is also plausible that the level of expression of CASP4 could 376 serve as a biomarker to identify patients who will succumb to severe Covid. Targeting CASP4 377 alone can achieve benefits that will exceed and replace the administration of a large number of 378 individual anti-inflammatory agents and anti-thrombotics given to SARS-CoV-2 patients. Further 379 research is needed to develop therapeutics in this regard. 

SARS-CoV-2 and the pandemic of COVID-19

Understanding the immunological 617 aspects of SARS-CoV-2 causing COVID-19 pandemic: A therapeutic approach

Elevated plasma IL-6 and CRP levels are associated with 620 adverse clinical outcomes and death in critically ill SARS-CoV-2 patients: inflammatory 621 response of SARS-CoV-2 patients

Pulmonary Endothelial Dysfunction and Thrombotic Complications 623 in Patients with COVID-19

Von Willebrand factor (vWF): marker of endothelial damage and 625 thrombotic risk in COVID-19

Ischemic stroke in COVID-19-627 positive patients: an overview of SARS-CoV-2 and thrombotic mechanisms for the 628 neurointerventionalist

Inflammasomes are activated in response to SARS-CoV-2 630 infection and are associated with COVID-19 severity in patients

Review 632 on therapeutic targets for COVID-19: insights from cytokine storm

Caspase-11 promotes the fusion of phagosomes harboring pathogenic 635 bacteria with lysosomes by modulating actin polymerization

CASP4/caspase-11 promotes autophagosome formation in response 637 to bacterial infection

The gasdermins, a protein family executing cell death 639 and inflammation

Caspase-11 cleaves gasdermin D for non-canonical inflammasome 641 signalling

SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 643 inflammasomes, pyroptosis and cytokine release

Caspase-11 Non-canonical Inflammasomes in the

A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and 647 Mortality in Standard Laboratory Mice

The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice

Evaluation of K18-hACE2 Mice as a Model of SARS-CoV-2

Caspase-11 counteracts mitochondrial ROS-mediated clearance of 653 Staphylococcus aureus in macrophages

Caspase-11 mediates migration of neutrophils and necroptosis 655 during acute gouty arthritis

Type I and III interferons disrupt lung epithelial repair during recovery 657 from viral infection

Quantification of histochemical staining by color 659 deconvolution

Neutrophil extracellular traps contribute to immunothrombosis in 661 COVID-19 acute respiratory distress syndrome

High risk of thrombosis in patients with severe SARS-CoV-2 infection: a 663 multicenter prospective cohort study

Effects of simulated COVID-19 cytokine storm on stent 665 thrombogenicity

Neutrophil extracellular traps infiltrate the lung airway, interstitial, 667 and vascular compartments in severe COVID-19

Increased sFLT-1/PlGF ratio in COVID-19: A novel link to angiotensin 669 II-mediated endothelial dysfunction

SARS-CoV-2 variants with mutations at the S1/S2 cleavage site are 671 generated in vitro during propagation in TMPRSS2-deficient cells

Bacterial Outer Membrane Vesicles Mediate Cytosolic Localization of 674 LPS and Caspase-11 Activation

Non-canonical inflammasome activation targets caspase-11

Caspase-11 non-canonical inflammasome: a critical sensor of intracellular 678 lipopolysaccharide in macrophage-mediated inflammatory responses

The cytokine storm in 681 COVID-19: An overview of the involvement of the chemokine/chemokine-receptor 682 system

SARS-CoV-2 nucleocapsid suppresses host pyroptosis by blocking 684

Acute respiratory distress 686 syndrome: a life threatening associated complication of SARS-CoV-2 infection inducing 687 COVID-19

SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro

Upregulation of pulmonary tissue factor, loss of 691 thrombomodulin and immunothrombosis in SARS-CoV-2 infection

SARS-CoV-2 infection reduces Kruppel-Like Factor 2 in human lung 694 autopsy

Pulmonary Vascular Endothelialitis, Thrombosis, and 696 Angiogenesis in Covid-19

Endothelial cell infection and endotheliitis in COVID-19

Efficacy and tolerability of bevacizumab in patients with severe Covid-19

Lethal infection of K18-hACE2 mice infected with severe acute 702 respiratory syndrome coronavirus

A Protocol for the Comprehensive Flow Cytometric Analysis of Immune 704 Cells in Normal and Inflamed Murine Non-Lymphoid Tissues

Elevated Expression of MiR-17 in Microglia of Alzheimer's Disease 707 Patients Abrogates Autophagy-Mediated Amyloid-beta Degradation

Related Peptide May Directly Regulate Kisspeptin Neurons in Male Sheep

Whole-Brain Vasculature Reconstruction at the Single Capillary 713

Advanced CUBIC protocols for whole-brain and whole-body clearing 715 and imaging

BISR-RNAseq: an 717 efficient and scalable RNAseq analysis workflow with interactive report generation

HISAT: a fast spliced aligner with low memory 720 requirements

featureCounts: an efficient general purpose program for 722 assigning sequence reads to genomic features

limma powers differential expression analyses for RNA-sequencing 724 and microarray studies

Enrichr: a comprehensive gene set enrichment analysis web 726 server 2016 update

10 5 pfu). d, Casp11 RNA (green, RNAscope in situ hybridization) and DAPI (blue) were visualized (3D Intensity projection image) in lung sections using 20x objective. e, Casp11 RNA levels were quantfied in lung samples (N=3) by qRT-PCR, unpaired t test. f, CASP11 protein levels in lungs described in d (N=3) were examined by Western blot. g, K18-hACE2 mice were infected for 4 days with human SARS-CoV-2 (WA1, 10 5 pfu) and Casp11 RNA levels were quantitated in lung samples (N=4) by qRT-PCR

TCID50 viral titers were quantified in lung tissue homogenates. c, Sections from non-infected control lungs or lungs collected at 4 days post-infection were stained for SARS-CoV-2 nucleocapsid protein (brown staining, images representative of at least 3 mice per group). d-f, WT, Casp11 -/-, and Gsdmd -/-mice (N=3) were infected with SARS-CoV-2 (MA10, 10 5 pfu) for 2 days. RNA was extracted from lungs and subjected to RNA sequencing. d, Principal component analysis (PCA) of SARS-CoV2-infected lung gene expression with points representing individual WT (grey), Casp11 -/-(blue), and Gsdmd -/-(green) mice. e, Top 30 significant Gene Ontology Biological Pathways are depicted. Node size indicates the number of transcripts within each functional category. Edges connect overlapping gene sets. Numbers represent individual replicates and color indicates relative upregulation (red) or downregulation (blue) in gene expression. f, Heatmap of significantly changed cytokine and chemokine genes when comparing Casp11

ANOVA with Tukey's multiple comparisons test. e,f, Macrophages were purified from lungs of mice of the indicated genotype. The cells were infected with mouse adapted SARS-CoV-2 (MOI 1) for 24 h. Cell supernatants were analyzed by ELISA, or cellular RNA was analyzed by qRT-PCR for the indicated chemokine/cytokines, ANOVA with Tukey's multiple comparisons test. g, Heatmap of significantly changed neutrophil-related genes comparing Casp11

Expression scaling is relative to WT and Gsdmd -/-mice for comparisons. Numbers represent individual replicates and color indicates relative upregulation (red) or downregulation (blue) in gene expression. h, Lung sections of day 2 SARS-CoV-2-infected WT, Casp11 -/-and Gsdmd -/-mice (N=5) stained with neutrophil marker Ly6G and quantified in i. j, Flow cytometry of lungs homogenates from mice WT (N=4)

Images were captured by a 20x objective in a 3D stitched panoramic view. Intensity projection images were created using IMARIS software. c, Western blotting of lung homogenates from non-infected WT and SARS-CoV-2-infected WT and Casp11 -/-mice as described in a were quantified in d, unpaired t test. e, qRT-PCR quantification of KLF2 in the lungs of mice as described in b, unpaired t test. f, Confocal microscopy for the colocalization of VWF RNA (green) with endothelial VEGF receptor subtype 1 (FLT1, red) in the lungs of mice as described in b. Nuclei were stained with DAPI (blue). Images were captured with a 20x objective in a z-stack 3D view and visualized using intensity projection function of IMARIS software. g, Vasculature imaging of intact lungs 4 days post-infection